ONWARD Announces Completion of Enrollment in the Up-LIFT Pivotal Trial of ARC Therapy for Spinal Cord Injury
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Breakthrough Device Designations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Enrollment was completed in less than 12 months despite COVID-related challenges, demonstrating strong interest in the therapy THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING
Press release content from Business Wire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, today announced its latest findings presented at the...
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, today announced its latest findings presented at the...